Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 382 participants.
Also called NCT04684498
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 382 participants
- Sponsor
- Registry
-
NCT04684498
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04684498. Randomized; no masking; primary purpose treatment. Start 2020-03-01 (actual); primary completion 2023-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients
- Condition
- ST Elevation Myocardial Infarction
- Condition
- STEMI
- Intervention (Drug)
- Oseltamivir phosphate capsules
- Lead sponsor
- Tongji Hospital
Record details
- Record id
cardio:ct-nct04684498- Content hash
886094b7c4b4f3646fa2ab93ecccfdc1e3f5d0363ebc7bba9baf256dd4835f0a